NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• Crude Inventory 0.4M Barrels Last Week - EIA
• This home improvement stock is best positioned for a rebound
• American Eagle Outfitters (AEO) PT Lowered to $16 at TD Cowen